BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19352605)

  • 1. [Advances in basic research on testicular germ cell tumors : clinical implications].
    Looijenga LH
    Urologe A; 2009 Apr; 48(4):350-8. PubMed ID: 19352605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
    Looijenga LH
    J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
    Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
    Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in testicular germ cell tumor research.
    van de Geijn GJ; Hersmus R; Looijenga LH
    Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
    Santagata S; Ligon KL; Hornick JL
    Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Embryonal germ cells and germ cell tumors].
    Biermann K; Heukamp LC; Nettersheim D; Steger K; Zhou H; Franke FE; Guetgemann I; Sonnack V; Brehm R; Berg J; Bastian PJ; Müller SC; Wang-Eckert L; Schorle H; Büttner R
    Verh Dtsch Ges Pathol; 2007; 91():39-48. PubMed ID: 18314594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
    Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
    Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
    Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
    Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.
    Chieffi P; Chieffi S
    J Cell Physiol; 2013 Aug; 228(8):1641-6. PubMed ID: 23359388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in molecular and cell biology of testicular germ-cell tumors.
    Chieffi P
    Int Rev Cell Mol Biol; 2014; 312():79-100. PubMed ID: 25262239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
    Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
    J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours.
    de Jong J; Stoop H; Dohle GR; Bangma CH; Kliffen M; van Esser JW; van den Bent M; Kros JM; Oosterhuis JW; Looijenga LH
    J Pathol; 2005 Jun; 206(2):242-9. PubMed ID: 15818593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
    Nonaka D
    Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oncofetal and developmental perspective on testicular germ cell cancer.
    Rijlaarsdam MA; Looijenga LH
    Semin Cancer Biol; 2014 Dec; 29():59-74. PubMed ID: 25066859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testicular cancer: biology and biomarkers.
    Looijenga LH; Stoop H; Biermann K
    Virchows Arch; 2014 Mar; 464(3):301-13. PubMed ID: 24487784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Circulating Tumor Cells (CTCs) in Patients with Testicular Germ Cell Tumors.
    Nastały P; Honecker F; Pantel K; Riethdorf S
    Methods Mol Biol; 2021; 2195():245-261. PubMed ID: 32852768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic Characterization of Bilateral Testicular Germ Cell Tumors With Immunohistochemical Evaluation of Mismatch Repair and
    Al-Obaidy KI; Trevino KE; Idrees MT
    Int J Surg Pathol; 2019 Sep; 27(6):619-623. PubMed ID: 30983459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
    Bu L; Yang Q; McMahon L; Xiao GQ; Li F
    Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
    Cao D; Li J; Guo CC; Allan RW; Humphrey PA
    Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.